This page lists the gynaecology hospitals in our directory offering Cervical Cerclage (Cervical Stitch) in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.
Ask us about cervical cerclage (cervical stitch) in Chennai, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 8 accredited hospitals for Gynaecology in Chennai, India
Featured🇮🇳 Apollo Hospitals, Greams Road
Ranks #1 in this list by listed rating (4.7/5 from 125 reviews).
🇮🇳 Gleneagles Global Hospital
Ranks #2 in this list by listed rating (4.7/5 from 112 reviews).
🇮🇳 Dr. Rela Institute and Medical Centre
Ranks #3 in this list by listed rating (4.7/5 from 108 reviews).
🇮🇳 SIMS Hospital
Ranks #4 in this list by listed rating (4.6/5 from 20 reviews).
🇮🇳 Sankara Nethralaya
Ranks #5 in this list by listed rating (4.4/5 from 220 reviews).
🇮🇳 Apollo First Med Hospitals, Kilpauk
Ranks #6 in this list by listed rating (4.4/5 from 76 reviews).
🇮🇳 MIOT International
Ranks #7 in this list by listed rating (4.4/5 from 200 reviews).
🇮🇳 MGM Healthcare
Ranks #8 in this list by listed rating (3.7/5 from 34 reviews).
How we selected these hospitals
A hospital appears on this page when Gynaecology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Cervical Cerclage (Cervical Stitch) in Chennai, India?
Choosing the right hospital for cervical cerclage (cervical stitch) is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include gynaecology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Cervical Cerclage (Cervical Stitch)
Cervical cerclage (cervical stitch) is a minimally invasive obstetric-gynecological surgical procedure in which a strong suture or synthetic tape is placed around the cervix to mechanically reinforce cervical incompetence and reduce the risk of second-trimester pregnancy loss or preterm birth, achieving success rates of 75–85% in appropriately selected candidates. International patients choose India and the UAE for this procedure because both destinations offer sub-specialist maternal-fetal medicine (MFM) units, ultrasound-guided placement techniques, and comprehensive antenatal monitoring at costs significantly below those in Western Europe or North America. GAF Healthcare connects patients to JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed facilities in Dubai and Abu Dhabi, providing end-to-end coordination from diagnostic workup through post-procedure surveillance. Hospital Stay: 1–2 days (day-surgery to overnight admission; longer if placed prophylactically under general/spinal anesthesia with observation) • Total Stay in Country (Fit-to-Fly): 2–4 weeks (patients require cervical rest, absence of uterine contractions, and a confirming ultrasound before international air travel is cleared by the treating MFM specialist) • Success Rate: 75–85% (prolongation of pregnancy to ≥34 weeks in women with cervical incompetence; up to 90% in purely mechanical/anatomical incompetence without co-existing infection or active preterm labor)
Clinical Overview
Cervical incompetence (also termed cervical insufficiency) is a structural or functional failure of the uterine cervix to remain closed and maintain adequate length during the second trimester of pregnancy, resulting in painless cervical dilation, membrane prolapse, and pregnancy loss typically between 14 and 28 weeks of gestation. The pathophysiology involves deficient collagen cross-linking and smooth-muscle architecture within the cervical stroma, which may be congenital (as in Müllerian anomalies or connective-tissue disorders such as Ehlers-Danlos syndrome), or acquired following large-loop excision of the transformation zone (LLETZ/LEEP), cone biopsy, cervical lacerations from prior deliveries, or uterine curettage. Sonographic surveillance demonstrating a short cervix (transvaginal ultrasound cervical length < 25 mm before 24 weeks) or a dilated internal os with funneling is the cornerstone of modern diagnosis, replacing the older historical and clinical diagnostic criteria. Cervical cerclage addresses this incompetence by placing a non-absorbable suture — most commonly braided polyester (Mersilene tape 5 mm) or Prolene — at the level of the internal os to provide mechanical support to the cervical canal throughout gestation. Three principal surgical techniques are employed: the McDonald cerclage (the most widely performed, placing a purse-string suture at the cervicovaginal junction under regional or general anesthesia), the Shirodkar cerclage (a higher, more anatomically precise placement requiring bladder dissection and submucosal tunneling to position the suture at the level of the internal os), and the transabdominal cerclage (TAC), which is placed laparoscopically or via open laparotomy at the cervico-isthmic junction for women with a history of failed vaginal cerclage, a severely shortened cervix due to prior surgery, or anatomical factors precluding a vaginal approach. Standard of care integrates pre-procedure cervicovaginal fetal fibronectin testing, high-vaginal swab cultures, and transperineal or transabdominal ultrasonography to exclude subclinical chorioamnionitis before suture placement. Both India and the UAE have invested substantially in maternal-fetal medicine subspecialty infrastructure. Leading tertiary hospitals in Mumbai, Delhi, Chennai, and Bengaluru operate dedicated high-risk pregnancy units with 24-hour fetal surveillance capabilities, while hospitals in Dubai (including Dubai Hospital, Mediclinic City, and American Hospital Dubai) and Abu Dhabi (Cleveland Clinic Abu Dhabi, Burjeel Medical City) provide DHA-regulated, internationally benchmarked antenatal and surgical services. The availability of MFM-trained sub-specialists who perform high-volume cerclage procedures — including laparoscopic transabdominal cerclage — at both destinations makes India and the UAE compelling options for international patients seeking expertise outside their home countries.
Who is a Candidate?
• IDEAL CANDIDATES — HISTORY-INDICATED (PROPHYLACTIC) CERCLAGE: • Women with a history of ≥1 second-trimester pregnancy losses or preterm births (< 34 weeks) attributed to painless cervical dilation in the absence of contractions or placental abruption • Women with a prior cervical cerclage that successfully prolonged a pregnancy • Women with a history of significant cervical surgery (cone biopsy, LEEP/LLETZ) resulting in measurable cervical shortening • Congenital Müllerian anomalies associated with cervical structural weakness • Diagnosis of connective tissue disorders (e.g., Ehlers-Danlos syndrome, Marfan syndrome) with documented cervical incompetence • ULTRASOUND-INDICATED (THERAPEUTIC/SECONDARY) CERCLAGE: • Asymptomatic pregnant women (typically 16–24 weeks) with transvaginal cervical length < 25 mm on serial ultrasound surveillance • Short cervix with funneling of the internal os (> 25% of cervical length) without active uterine contractions • Particularly indicated if short cervix coexists with prior spontaneous preterm birth history (combined risk > 70% of recurrent preterm birth at < 35 weeks) • RESCUE (EMERGENCY/PHYSICAL EXAMINATION-INDICATED) CERCLAGE: • Patients at 16–26 weeks with an acutely dilated cervix (typically 1–4 cm) with or without bulging membranes visible at or beyond the external os • Decision must exclude active chorioamnionitis, active labor, placental abruption, and fetal anomalies incompatible with life • REQUIRED DIAGNOSTIC WORKUP PRIOR TO PROCEDURE: • Transvaginal ultrasound (TVUS) for precise cervical length measurement (ideally ≥ 2 serial measurements ≥ 1 week apart for ultrasound-indicated cases) • High-vaginal swab and cervical cultures (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas, group B Streptococcus, bacterial vaginosis assessment) • Cervicovaginal fetal fibronectin (fFN) — positive result increases rescue cerclage risk assessment • Detailed fetal anomaly ultrasound (to exclude major structural abnormalities or aneuploidy before committing to cerclage) • Amniocentesis and amniotic fluid interleukin-6 (IL-6), glucose, white-cell count, and culture in rescue cerclage cases to exclude subclinical intra-amniotic infection • Full blood count, CRP, procalcitonin (infection markers) • Karyotyping or chromosomal microarray if fetal anomalies suspected • Maternal thrombophilia screen (antiphospholipid antibodies, factor V Leiden) in patients with recurrent pregnancy loss • Uterine cavity assessment: saline-infusion sonohysterography (SIS) or MRI pelvis to evaluate for co-existing uterine anomalies • CONTRAINDICATIONS (ABSOLUTE): • Active intra-amniotic infection (chorioamnionitis) — confirmed by amniotic fluid analysis • Active preterm labor with regular painful uterine contractions • Placenta previa or active antepartum haemorrhage • Fetal demise or lethal fetal anomaly • Preterm premature rupture of membranes (PPROM) • Gestational age > 26+6 weeks (generally; individual specialist assessment required for rescue cases) • RELATIVE CONTRAINDICATIONS: • Uncontrolled maternal medical conditions (e.g., poorly controlled diabetes, severe pre-eclampsia) • Active genital herpes outbreak • Significant uterine irritability without confirmed labor
Treatment Options & Approaches
TECHNIQUE 1 — McDONALD CERCLAGE (VAGINAL, PURSE-STRING): The McDonald technique is the most commonly performed vaginal cerclage worldwide and the first-line choice for most candidates. Under spinal or general anesthesia (procedure duration 15–30 minutes), the surgeon places a braided polyester suture (Mersilene 5 mm tape or equivalent non-absorbable material) in a purse-string fashion circumferentially around the cervix at the cervicovaginal junction, as high as anatomically achievable vaginally. The knot is tied anteriorly for easy identification and removal. No bladder dissection is required. The suture is routinely removed at 36–37 weeks of gestation or earlier if labor establishes. The McDonald technique is associated with minimal operative time, low intraoperative blood loss, and rapid recovery, making it the preferred approach for both prophylactic and ultrasound-indicated cerclage placement. TECHNIQUE 2 — SHIRODKAR CERCLAGE (VAGINAL, SUBMUCOSAL HIGH PLACEMENT): The Shirodkar technique involves reflecting the vaginal mucosa anteriorly and posteriorly to allow submucosal placement of the non-absorbable suture (typically Mersilene tape) at the anatomical level of the internal cervical os — significantly higher than the McDonald suture position. This approach requires greater surgical expertise, bladder mobilization, and repair of the vaginal epithelium. While theoretically achieving a more physiologically correct placement, meta-analyses have not demonstrated consistently superior perinatal outcomes compared to the McDonald technique in head-to-head randomized studies. The Shirodkar suture may be left permanently in situ (requiring elective caesarean delivery) or removed at 37 weeks to permit vaginal delivery. TECHNIQUE 3 — TRANSABDOMINAL CERCLAGE (TAC): OPEN vs. LAPAROSCOPIC: Transabdominal cerclage is reserved for patients in whom vaginal cerclage has previously failed (suture cut through cervical tissue) or for women with an extremely short, amputated, or surgically absent cervix that precludes vaginal suture placement. A 5 mm Mersilene mesh tape is placed at the cervico-isthmic junction through either a Pfannenstiel laparotomy incision or, increasingly, via laparoscopic (minimally invasive) access using 3–4 ports and high-definition magnification. Laparoscopic TAC offers shorter hospital stay (1–2 days vs. 3–5 days for open), reduced blood loss (< 50 mL vs. 100–200 mL), faster return to daily activities (1 week vs. 2–3 weeks), and equivalent procedural success rates to open TAC. Several high-volume centers in India and the UAE now perform laparoscopic TAC as a day-surgery procedure. TAC is a permanent placement; all subsequent deliveries must be by elective caesarean section. It may be placed between pregnancies (interval TAC) or during the first trimester (12–14 weeks) under direct vision. TECHNIQUE 4 — RESCUE (EMERGENCY) CERCLAGE WITH MEMBRANE REDUCTION: In cases of an acutely dilated cervix with bulging membranes at 16–26 weeks, rescue cerclage is performed after membrane reduction using Trendelenburg positioning, bladder filling (retrograde instillation of 500–750 mL saline to reduce membrane prolapse), and occasionally a No. 30 Foley balloon. Amniocentesis to exclude intra-amniotic infection (IAI) should ideally precede rescue cerclage; if IAI is excluded, cerclage can extend pregnancy by a median of 5–9 weeks and improve perinatal survival. Procedurally, rescue cerclage most commonly uses the McDonald technique, modified Shirodkar, or an emergency TAC in specialist centers. ADJUNCT PHARMACOLOGICAL & MONITORING PROTOCOLS: • Progesterone supplementation (vaginal micronized progesterone 200–400 mg nightly or 17-alpha-hydroxyprogesterone caproate 250 mg IM weekly) is routinely combined with cerclage for synergistic risk reduction in women with prior preterm birth and short cervix. • Tocolytics (indomethacin 25–50 mg orally/rectally perioperatively for 48 hours; or nifedipine) are used to suppress post-procedural uterine irritability. • Prophylactic antibiotics (typically cefazolin IV intraoperatively, followed by a short course of oral amoxicillin-clavulanate or erythromycin) are administered per institutional protocol. • Cervical length surveillance by TVUS every 2–4 weeks post-cerclage is standard of care for monitoring suture integrity and residual cervical length. • Cervicovaginal fetal fibronectin testing at 22–28 weeks can risk-stratify for premature rupture of membranes despite cerclage. • Antenatal corticosteroids (betamethasone 12 mg IM × 2 doses, 24 hours apart) are administered if preterm delivery appears imminent between 24–34 weeks, even in the presence of a cerclage.
Recovery
PHASE 1 — PRE-PROCEDURE EVALUATION (Days –14 to –3 before cerclage): International patients arriving in India or the UAE for cerclage undergo a structured pre-admission workup coordinated by GAF Healthcare. This includes a telemedicine consultation with the MFM sub-specialist prior to travel, followed by in-country transvaginal ultrasound for precise cervical length measurement, high-vaginal swab cultures, complete blood count, CRP, blood group and screen, and a detailed morphology ultrasound at 18–20 weeks (if not already performed). For rescue cerclage candidates, emergency admission is coordinated directly on arrival. Anaesthesia review is completed, and the surgical technique (McDonald, Shirodkar, or laparoscopic TAC) is confirmed based on clinical findings and surgical history. PHASE 2 — ADMISSION DAY (Day 0): The patient is admitted on the morning of the procedure (or the evening prior for planned general anaesthesia). A final bedside TVUS confirms cervical status. Informed consent covers the specific technique, anesthetic approach, procedural risks (rupture of membranes, chorioamnionitis, preterm labor, suture displacement), and alternative management options. Fasting per standard anaesthetic guidelines (6 hours for solids, 2 hours for clear fluids) is observed. IV access is established, prophylactic antibiotics are administered, and tocolytic premedication (typically indomethacin) is given. PHASE 3 — THE PROCEDURE (Duration: 15–45 minutes depending on technique): McDonald or Shirodkar cerclage: performed in the operating theatre under spinal anaesthesia (preferred) or general anaesthesia. The patient is positioned in the dorsal lithotomy position. The surgeon identifies the cervicovaginal junction, positions the Mersilene tape under direct visualization with a headlight or operating scope, and completes the purse-string suture. Intraoperative TVUS may confirm suture position and post-placement cervical length. Laparoscopic TAC: the patient is placed in steep Trendelenburg. Three or four laparoscopic ports are inserted. The uterovesical peritoneum is mobilized, the uterine vessels are identified and retracted, and the 5 mm Mersilene tape is passed medial to the uterine vessels at the cervico-isthmic junction using a curved needle carrier. The tape is secured with a non-slip knot anteriorly or posteriorly. CO₂ pneumoperitoneum is deflated and ports are closed. PHASE 4 — IMMEDIATE POST-OPERATIVE MONITORING (Days 1–2): The patient remains in the recovery unit for 2–4 hours post-procedure with continuous fetal heart rate monitoring (cardiotocograph, CTG) to confirm fetal wellbeing. Vital signs, uterine activity monitoring, and vaginal bleeding assessment are performed hourly. Tocolytic therapy (indomethacin or nifedipine) is continued for 24–48 hours. A post-procedure TVUS is performed on day 1 to confirm suture position and measure residual cervical length above the cerclage. If stable, the patient is discharged with written instructions regarding pelvic rest (absolute avoidance of sexual intercourse), activity restriction, and warning signs (fever > 37.8°C, regular contractions, increased vaginal discharge, rupture of membranes). PHASE 5 — IN-COUNTRY OBSERVATION PERIOD (Weeks 1–4 post-procedure): Patients remain in India or the UAE for a minimum of 2 weeks (typically 3–4 weeks for rescue cerclage or laparoscopic TAC cases) to allow: • Confirmation of absence of post-procedural chorioamnionitis or premature rupture of membranes • Follow-up TVUS at 10–14 days to confirm suture integrity and residual cervical length • Fetal wellbeing assessment (biophysical profile if indicated) • Wound check for laparoscopic port sites (TAC cases) Fit-to-fly clearance is issued by the MFM specialist after the follow-up scan confirms no cervical change, no membrane prolapse, and fetal heart rate is normal. Patients are supplied with a detailed clinical summary, operative notes, post-procedure imaging, and a management plan for their home obstetrician. PHASE 6 — LONG-TERM FOLLOW-UP (Home country, weeks 4 onward through delivery): Cervical length surveillance every 2–4 weeks via TVUS in the home country. Continuation of vaginal progesterone or 17-OHPC injections as prescribed. Planning for elective caesarean delivery at 37–38 weeks (TAC) or suture removal at 36–37 weeks with anticipated vaginal delivery (McDonald/Shirodkar). Administration of antenatal corticosteroids if early delivery is anticipated. Emergency management plan for PPROM or threatened preterm labor is provided to the patient in written form for presentation to local emergency obstetric services.
Risks to be aware of
Cervical cerclage is considered a low-to-moderate risk obstetric surgical procedure when performed in appropriately selected patients by experienced MFM surgeons, but carries specific risks that patients must understand before consenting. Procedural risks include: premature rupture of membranes (PROM) occurring in 1–5% of cases (higher in rescue cerclage, up to 10–15%); inadvertent rupture of the amniotic membranes during suture placement; cervical laceration or bleeding from suture cutting through friable or infected cervical tissue; and bladder injury during Shirodkar or laparoscopic TAC (requiring intraoperative repair). Infectious complications represent the most clinically significant risk category. Subclinical intra-amniotic infection (IAI) — defined by amniotic fluid glucose < 14 mg/dL, IL-6 > 2.6 ng/mL, or positive amniotic fluid culture — is both a contraindication to cerclage and a potential post-procedure complication. Post-cerclage chorioamnionitis occurs in approximately 2–8% of elective cases and up to 30% of rescue cerclage cases, and mandates immediate suture removal and delivery regardless of gestational age. Obstetric risks include: stimulation of preterm uterine contractions (requiring additional tocolytic therapy), cervical dystocia at the time of labour if the suture is not removed, and failure of the cerclage (suture displacement or cut-through in 3–7% of cases requiring re-placement or escalation to transabdominal approach). In laparoscopic TAC, general surgical risks apply: venous thromboembolism, anaesthetic complications, port-site hernia (< 1%), and uterine vessel injury (< 1% in specialist hands). Anesthetic risks depend on the chosen modality: spinal anaesthesia carries a risk of post-dural puncture headache (1–3%), hypotension requiring vasopressor support, and rare neurological complications. General anaesthesia in pregnant patients carries an elevated risk of aspiration, difficult airway management, and neonatal respiratory depression if exposure is prolonged. Long-term considerations include: cervical stenosis following repeated cerclage placements; the psychological burden of high-risk pregnancy management; and the absolute requirement for caesarean delivery in all future pregnancies following transabdominal cerclage, which carries its own surgical risk profile. Patients with rescue cerclage have perinatal mortality rates of 5–15% even with successful suture placement, largely driven by the extreme prematurity of delivery rather than the procedure itself. Transparent pre-procedure counselling by an MFM specialist is essential to ensure realistic expectations.
Why GAF Healthcare
GAF Healthcare provides comprehensive non-medical coordination for all international patients travelling to India or the UAE for cervical cerclage, ensuring that logistical complexity does not delay access to time-sensitive obstetric care. INDIA — VISA & ENTRY: Most international patients travelling to India for medical treatment are eligible for the e-Medical Visa (e-MV), which is available online through the Indian government's official portal and is granted for up to 60 days with triple-entry validity. GAF Healthcare's visa coordination team assists with the application process, including preparation of the hospital invitation letter, treatment confirmation documents, and required medical records, typically achieving approval within 3–5 business days. A companion (attendant) e-Medical Attendant Visa is simultaneously processed for the patient's accompanying family member or support person. UAE (DUBAI / ABU DHABI) — VISA & ENTRY: The UAE offers visa-free entry or visa-on-arrival to citizens of over 120 countries, including EU member states, the United Kingdom, the United States, Canada, Australia, and GCC nationals. Patients from countries requiring pre-arranged visas receive support from GAF Healthcare in obtaining a UAE Medical Visit Visa through the sponsoring hospital, typically processed within 3–5 working days. DHA (Dubai Health Authority) and DOH (Department of Health Abu Dhabi) regulated hospitals accept international insurance panels, and GAF Healthcare assists with pre-authorisation letters for insured patients. AIRPORT TRANSFERS & IN-COUNTRY TRANSPORT: All patients receive private, climate-controlled vehicle transfers between the international airport and the hospital upon arrival and departure. For high-risk pregnant patients, arrangements include vehicles equipped for patient comfort and, where clinically indicated, coordination with emergency medical services for transfers. Wheelchair assistance and priority boarding coordination at airports are arranged upon request. DEDICATED PATIENT COORDINATOR & TRANSLATION SERVICES: Each patient is assigned a personal GAF Healthcare case manager who serves as the single point of contact from the initial inquiry through post-discharge follow-up. For patients whose primary language is not English or the local language, certified medical interpreters (covering Arabic, Russian, French, Swahili, Bangla, and other major languages) are available in-person or via teleinterpretation for all consultations, consent processes, and discharge counselling sessions. Written medical documents including discharge summaries, operative notes, and post-cerclage surveillance plans are translated into the patient's preferred language. ACCOMMODATION FOR PATIENTS & ATTENDANTS: Given that international patients are required to remain in-country for 2–4 weeks post-cerclage (to complete follow-up surveillance before fit-to-fly clearance), GAF Healthcare arranges serviced apartments or hotel accommodation within close proximity to the treating hospital. Options range from budget-friendly serviced residences to premium hotel apartments, all vetted for suitability for pregnant patients (including elevator access, proximity to pharmacy services, and dietary catering). Accommodation for one accompanying attendant is included in all standard GAF Healthcare care packages. TELEMEDICINE FOLLOW-UP: Following return to the home country, GAF Healthcare facilitates scheduled telemedicine follow-up consultations with the treating MFM specialist at 2-week intervals through 28 weeks of gestation, and as clinically indicated thereafter. Digital sharing of TVUS images and cervical length measurements from the home obstetrician enables remote monitoring continuity and ensures the treating specialist can advise on management in real time.
Common questions about Cervical Cerclage (Cervical Stitch)
What is the cost of Cervical Cerclage (Cervical Stitch) in India vs. the UAE?
How long do I need to stay in India or the UAE before I am fit to fly home after cervical cerclage?
What is the success rate of cervical cerclage?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Cervical Cerclage (Cervical Stitch) in Chennai, India
Discover the Top Hospitals for Cervical Cerclage (Cervical Stitch) in Chennai, India
This page lists 8 accredited gynaecology hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about cervical cerclage (cervical stitch) in Chennai, India
How many gynaecology hospitals are listed in Chennai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there gynaecology hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for cervical cerclage (cervical stitch) in Chennai, India.
Contact us to report an inaccuracy on this page.